GSC
VANI icon

Ground Swell Capital’s Vivani Medical VANI Stock Holding History

Ground Swell Capital’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,608
Closed -$15.9K – 267
2024
Q2 		$15.9K Buy
+12,608
New +$21.6K 0.01% 138

Other funds holding VANI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ground Swell Capital's VANI Position: Q3 2024 in Review

Ground Swell Capital sold out of Vivani Medical (VANI) in Q3 2024, closing a stake of 12,608 shares — an estimated $15.9K sold.

Ground Swell Capital first reported a position in VANI in Q2 2024 and held it in 1 quarter. The position peaked at $15.9K in Q2 2024. 28 funds tracked by Wall St. Rank hold VANI as of Q3 2024.

  • Ground Swell Capital reported no remaining Vivani Medical position as of Q3 2024 after selling out during the quarter.
  • Ground Swell Capital sold 12,608 Vivani Medical shares in Q3 2024, an estimated $15.9K.
  • Ground Swell Capital first reported a position in Vivani Medical in Q2 2024 and held it in 1 quarter.
  • Ground Swell Capital's Vivani Medical position peaked at $15.9K in Q2 2024.
  • 28 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2024.

Based on Ground Swell Capital's 13F filing for Q3 2024, filed 29 Oct 2024.